GenSight Biologics SA Financial Overview
GenSight Biologics SA's market cap is currently €19.01M. The company's EPS TTM is €-0.05; its P/E ratio is -0.77; GenSight Biologics SA is scheduled to report earnings on September 29, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
